OpenAI Collaborates with a Longevity Startup to Counter Age-Related Health Issues

www.analyticsdrift.com

Image source: Analytics Drift

OpenAI and Retro Biosciences, a longevity startup, have come together to train a micro-AI model, GPT-4b, which will improve stem cell production.

Image source: AD

OpenAI Teams up with Retro Biosciences

Previously, Google DeepMind’s AlphaFold dominated the AI Bioengineering application, as it facilitated the structure of protein structures.

Image source: Google

Past Contribution of AI in Biomedical Domain

According to the OpenAI researchers, GPT-4b is said to visualize proteins that transform regular adult cells into stem cells. This feature overpowers the capability of the DeepMind’s AlphaFold, as it improves stem cell production efficiency.

Image source: AD

How GPT-4b Prevails Google’s DeepMind

Although in its micro stage, the model can help re-engineer the Yamanaka factor, representing four genes responsible for combatting aging issues.

Image source: Canva

GPT-4b Expected to Optimize Yamanaka Factor

Referred to as a small language model (SLM), GPT-4b is trained using data on different protein species and the interaction process of different cells.

Image source: AD

Model Training Data for GPT-4b

As Retro Biosciences has been working towards increasing human lifespan by 10 years, it is gaining traction from tech giants. Sam Altman, CEO of OpenAI, has already funded this protein engineering project with a total of $180 Million.

Image source: Canva

Funding the Future of Biomedical Engineering